Budget Impact Analysis of Warfarin Reversal Therapies Among Hip Fracture Patients in Finland

por Purmonen, Timo, Törmälehto, Soili, Säävuori, Niina, Kokki, Hannu
Publicado no Drugs R D (2015)

Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective

por Purmonen, Timo, Puolakka, Kari, Bhattacharyya, Devarshi, Jain, Minal, Martikainen, Janne
Publicado no Cost Eff Resour Alloc (2018)

Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland

por Purmonen, Timo, Puolakka, Kari, Mishra, Dinesh, Gunda, Praveen, Martikainen, Janne
Publicado no Clinicoecon Outcomes Res (2019)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction

por Huusko, Jenni, Purmonen, Timo, Toppila, Iiro, Lassenius, Mariann, Ukkonen, Heikki
Publicado no ESC Heart Fail (2020)

Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use

por Huusko, Jenni, Kurki, Samu, Toppila, Iiro, Purmonen, Timo, Lassenius, Mariann, Gullberg, Elisabet, Wirta, Sara Bruce, Ukkonen, Heikki
Publicado no ESC Heart Fail (2019)

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care

por Korolainen, Minna A., Kurki, Samu, Lassenius, Mariann I., Toppila, Iiro, Costa-Scharplatz, Madlaina, Purmonen, Timo, Nissilä, Markku
Publicado no J Headache Pain (2019)

Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare

por Korolainen, Minna A., Tuominen, Samuli, Kurki, Samu, Lassenius, Mariann I., Toppila, Iiro, Purmonen, Timo, Santaholma, Jaana, Nissilä, Markku
Publicado no J Headache Pain (2020)